Cells have been growing in the dish for over 100 years as tools for discovery. Now cells have become promising new therapies. As the most important metric, cell...

Contract development and manufacturing organizations (CDMOs) occupy a unique position in the pharmaceutical industry. They have the great opportunity of being a...

As EBR evolves, Augmented Bath Records will elevate and empower an organization's human workforce. Organizations can augment existing content, execute on any de...

In this presentation, I will outline best practices for using vaporized hydrogen peroxide for bio-decontamination in isolators, restricted access barrier system...

Ongoing research and learnings in In Vitro Fertilization (IVF) programs provide a strong foundation specific to optimizing the in vitro culture environment of t...

Single use centrifuge advances in cell culture processing techniques have evolved from traditional centrifugation and filtration. The Biopharma Industry requir...

During product planning, you must acknowledge the uncertainty associated with the risks in your operating climate. Assessing these risks and how they manifest i...

Efficient and flexible facilities are designed with an optimal cost of goods, maximum yield, while maintaining flexibility to support changes in the production ...

This presentation highlights several bullet points: - 5.0 μm particles and a general comparison of EU and FDA approaches to cleanroom specification/testing; cri...

Single-pass tangential flow filtration (SPTFF) has become a popular method of choice in bioprocessing for purposes of volume reduction, process intensification ...

Advanced therapy medicinal product processes have fallen back on manual operations to accommodate the patient-specific scale, but what will these facilities loo...

The increasing demands of high productivity microbial fermentation for biologic manufacturing has resulted in a progression of improvements in the engineering a...

This paper will present the industry collaborations that have formed to address concerns about supply chain management, particulates, extractables, system integ...

Freeze drying has traditionally been a batch process making it both time consuming and energy intensive. While the use of new process analytical technology has ...

SP Scientific is a leading manufacturer of freeze dryers and aseptic fill-finish equipment. The company's Line of Sight approach provides a breakthrough suite o...

Paragon Bioservices Inc., a biologics Contract Development and Manufacturing Organization (CDMO) located in downtown Baltimore, has been experiencing considerab...

With the recent FDA approval of the CAR-T cell therapies Kymriah® from Novartis and Yescarta® from Kite Pharma there has been a renewed interest in bioprocessin...

The inter-facility management of freeze/thaw processes of drug substances has been a challenge fraught with issues that affect sites around the globe. Drug manu...

Usage of single-use technologies in both clinical and commercial applications is rapidly growing. A comparison between traditional reusable final fill componen...

The BioPhorum Technology Roadmap team, consisting of multiple end-user and supplier companies published a Biomanufacturing Technology Roadmap in July 2017. As ...

The suitability of the Xelum® continuous manufacturing technology for small-scale batches from 1 to 100 kg will be demonstrated. Furthermore, the new benchmark ...

The industry is changing fast in the cell and gene therapy arena. Producers are changing their approach from biosafety cabinets to isolators. CRB's aseptic proc...

In the cell and gene therapy modality there is often a debate on scaling up versus scaling out. Whilst there are multiple multi layered culture ware with auto...

Do not let your imported tableting and encapsulating machines be detained by U.S, Customs. Your purchasing agent or broker may not be aware of the need to info...

Use of Protein A along with salt gradient platform to capture monoclonal antibodies (mAbs) has been the practice for the past twenty-five years. However, Protei...

Risks management represent an essential step in the process validation implementation during all the life cycle of a given pharmaceutical plant from its concept...

While advanced aseptic processing is now well-rooted within the industry, the challenge has shifted from simply achieving the fundamental 'advanced' attributes ...

This is your opportunity to enjoy a networking reception within the newly formed INNOPHEX.

About 45% of drug and device recalls are due to design issues. These defects represent the main source of risks that, if furthermore neglected, can trigger sign...

This interactive panel discussion will focus on three distinct phases in the evolution of a start-up – growth planning for validation and small-batch manufactur...

With the advent of increasingly potent compounds such as ADCs and the greater prevalence of toxic aseptic applications, the understanding of product characteris...

Despite the billions being invested in protecting products and securing the supply chain, we are not seeing a material decrease in issues. The gray market is s...

The presentation presents and analyzes the different regulatory requirements related to cleaning and disinfection program. The presentation discusses the differ...

Tour Leaders: Tulsi Patel, John Niziolek Through the adoption and implementation of technology, life sciences companies are now realizing the full potential o...

Tour Leaders: Jason Collins, Rob Roy, Paul Valerio Take your aseptic processes to the next level as you hear about "internet of things" case studies showcasing...

Tour Leaders: Pat Bucklin, Dennis Powers, Tom Piombino We need to complete the mission of getting critical medicines and innovative therapies to patients soon...

Tour Leaders: Sherry Chen, Tim Schuster IPS understands that the dynamics of biopharmaceutical manufacturing are changing. Meet the vendors working with clien...

Tour Leaders: Brian Egan, Lonna Gordon, Sam Halaby, Mike Vileikis The Tour features revolutionary, technical, and "internet of things" concepts applied to pha...

Last year's Facility Focus survey identified Single Use as the single most useful technology to improve facility flexibility, manufacturing efficiency and utili...

Many existing active pharmaceutical ingredients (API's) and new chemical entities (NCE's) are poorly water soluble and subsequently have low oral bioavailabilit...

ISO50001 is a guideline for manufacturers to reduce energy consumption. Pharma end users adopt this program to improve environmental impact & reduce utility co...

Current single use microbial fermentors and cell culture bioreactors are not pressurized due to a limitation that the bag is generally unconstrained at the top ...

A brief outlook on the relevant cryo-storage requirements on the GMP manufacturing of ATMPs will be offered followed by a technical review of a modern cryovials...